Key Points:
- The World Health Organization Framework Convention on Tobacco Control (FCTC) Conference of the Parties (COP11) will be held in November in Geneva to discuss global tobacco control policies.
- Advocates for Tobacco Harm Reduction (THR) are concerned that the conference may not make substantial progress and may only prevent policies from worsening.
- CAPHRA criticizes COP11 for restricting public participation in the registration system and calls for broader discussion.
- THR advocates plan to hold opposing activities during COP11, providing evidence on the safety of nicotine products to push for policy change.
On September 30, 2025 - According to a report by Filtermag on September 29, the 11th Conference of the Parties (COP11) to the World Health Organization's Framework Convention on Tobacco Control will be held in Geneva in November. Representatives from various countries will discuss tobacco control policies. Against the backdrop of the World Health Organization's long-standing opposition to Tobacco Harm Reduction (THR), THR advocates are concerned that the meeting may only manage to avoid further harm to policies, rather than make substantial progress.
The COP10 failed to make progress in reducing global deaths related to smoking, partly because the voices of affected populations were not fully heard. Advocates for Tobacco Harm Reduction criticized the high public participation threshold at the global tobacco control conference, which restricted discussions on safer nicotine products. As COP11 approaches, the Asia-Pacific Harm Reduction Advocates Alliance (CAPHRA) has criticized the registration system for the conference and is calling for broader public participation.
The agenda of COP11 focuses on reducing tobacco consumption and nicotine addiction, but THR advocates believe this may undermine efforts to reduce the harm caused by tobacco. In order to change the direction of policy, THR advocates will hold similar opposing activities during the conference, providing evidence on the safety of nicotine products.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
